XWELL Inc.
XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport empl… Read more
Market Cap & Net Worth: XWELL Inc. (XWEL)
XWELL Inc. (NASDAQ:XWEL) has a market capitalization of $8.13 Million ($8.13 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #33901 globally and #11066 in its home market, demonstrating a 8.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying XWELL Inc.'s stock price $1.41 by its total outstanding shares 5766703 (5.77 Million).
XWELL Inc. Market Cap History: 2015 to 2026
XWELL Inc.'s market capitalization history from 2015 to 2026. Data shows change from $17.09 Billion to $8.13 Million (-54.08% CAGR).
Index Memberships
XWELL Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2698 of 3165 |
Weight: XWELL Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
XWELL Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how XWELL Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.26x
XWELL Inc.'s market cap is 0.26 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $17.09 Billion | $22.69 Million | -$11.16 Million | 753.41x | N/A |
| 2016 | $14.74 Billion | $18.97 Million | -$24.01 Million | 776.84x | N/A |
| 2017 | $9.48 Billion | $48.82 Million | -$28.84 Million | 194.18x | N/A |
| 2018 | $1.11 Billion | $50.09 Million | -$37.20 Million | 22.10x | N/A |
| 2019 | $231.82 Million | $48.52 Million | -$21.22 Million | 4.78x | N/A |
| 2020 | $137.25 Million | $8.38 Million | -$90.49 Million | 16.37x | N/A |
| 2021 | $232.97 Million | $73.73 Million | $3.35 Million | 3.16x | 69.57x |
| 2022 | $41.52 Million | $55.94 Million | -$32.84 Million | 0.74x | N/A |
| 2023 | $10.03 Million | $30.11 Million | -$27.74 Million | 0.33x | N/A |
| 2024 | $8.71 Million | $33.90 Million | -$16.85 Million | 0.26x | N/A |
Competitor Companies of XWEL by Market Capitalization
Companies near XWELL Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to XWELL Inc. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
XWELL Inc. Historical Marketcap From 2015 to 2026
Between 2015 and today, XWELL Inc.'s market cap moved from $17.09 Billion to $ 8.13 Million, with a yearly change of -54.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.13 Million | +205.99% |
| 2025 | $2.66 Million | -69.48% |
| 2024 | $8.71 Million | -13.22% |
| 2023 | $10.03 Million | -75.83% |
| 2022 | $41.52 Million | -82.18% |
| 2021 | $232.97 Million | +69.75% |
| 2020 | $137.25 Million | -40.80% |
| 2019 | $231.82 Million | -79.06% |
| 2018 | $1.11 Billion | -88.32% |
| 2017 | $9.48 Billion | -35.68% |
| 2016 | $14.74 Billion | -13.77% |
| 2015 | $17.09 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of XWELL Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.13 Million USD |
| MoneyControl | $8.13 Million USD |
| MarketWatch | $8.13 Million USD |
| marketcap.company | $8.13 Million USD |
| Reuters | $8.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.